For technical assistance or to report a suspected adverse drug reaction, contact MSD Animal Health at 0119239300.
Bravecto® Reg No G4083 (Act 36/1947) each chew contains 25 mg Fluralaner per kg body weight ZA/BRV/1117/0039. Bravecto® Spot-On Reg. No. G4292 (Act 36/1947) each 1 m? of Bravecto® Spot-On contains 280 mg fluralaner.
Bravecto® Chew: Commonly observed adverse reactions in clinical trials (1,6 % of treated dogs) were mild and transient gastrointestinal effects such as diarrhoea, vomiting, inappetence, and drooling. Adverse events reported to date are classified as rare. Convulsions and lethargy have been reported very rarely in spontaneous (pharmacovigilance) reports.
References: 1. Bravecto® package insert, MSD Animal Health, 2017 2. Burgio et al. Parasites & Vectors (2016) 9:626. 3. Taenzler et al. Parasites & Vectors (2014) 7:567. 4. Wengenmayer et al. Parasites & Vectors (2014) 7:525.